Novavax Inc (NVAX) stock
NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.96+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
Novavax total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2015 it was $395.00K, down 60.4% from the year before. The highest annual figure on record is $1.88M in fiscal 2013.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $395.00K | -60.4% |
| FY2014 | Dec 31, 2014 | $998.00K | -46.9% |
| FY2013 | Dec 31, 2013 | $1.88M | +149.8% |
| FY2012 | Dec 31, 2012 | $753.00K | +151.0% |
| FY2011 | Dec 31, 2011 | $300.00K | -6.3% |
| FY2010 | Dec 31, 2010 | $320.00K | – |
See a number that looks wrong?